Home Cart Sign in  
Chemical Structure| 1394371-71-1 Chemical Structure| 1394371-71-1

Structure of MK8722
CAS No.: 1394371-71-1

Chemical Structure| 1394371-71-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

MK-8722 is a potent, direct, allosteric activator of all twelve mammalian AMPK complexes.

Synonyms: MK8722

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of MK8722

CAS No. :1394371-71-1
Formula : C24H20ClN3O4
M.W : 449.89
SMILES Code : O[C@H]1[C@](OC[C@H]2OC3=NC4=NC(C5=CC=C(C6=CC=CC=C6)C=C5)=C(Cl)C=C4N3)([H])[C@]2([H])OC1
Synonyms :
MK8722
MDL No. :MFCD31715423
InChI Key :XQMNBTZLYOOAGA-UGESXGAOSA-N
Pubchem ID :89558344

Safety of MK8722

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of MK8722

epigenetics
PI3K-AKT

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
SKOV3 cells 20 μM, 40 μM 48 hours MK8722 inhibited the proliferation and migration of SKOV3 cells. Theranostics. 2024 Jan 1;14(1):75-95
OV90 cells 20 μM, 40 μM 48 hours MK8722 inhibited the proliferation and migration of OV90 cells. Theranostics. 2024 Jan 1;14(1):75-95
A2780 cells 20 μM, 40 μM 48 hours MK8722 inhibited the proliferation and migration of A2780 cells. Theranostics. 2024 Jan 1;14(1):75-95
mouse skeletal muscle cells 10 μM 50 minutes To evaluate the effect of MK8722 on glucose uptake in skeletal muscle cells, results showed that MK8722 significantly increased glucose uptake. Mol Metab. 2021 Sep;51:101228
mouse skeletal muscle cells 10 μM 50 minutes To evaluate the effect of MK8722 on glucose uptake in skeletal muscle cells, results showed that MK8722 significantly increased glucose uptake. Mol Metab. 2021 Sep;51:101228
C2C12 cells 1 μM MK-8722 stimulates AMPK signaling at 1 μM concentration without increasing α-Thr172 phosphorylation Biochem J. 2022 Jun 17;479(11):1181-1204
HEK293T/17 cells 1.2–5.6 μM MK-8722 activates AMPK in vitro, but EC50 values were 100–1000-fold higher than previously reported Biochem J. 2022 Jun 17;479(11):1181-1204
Human umbilical vein endothelial cells (HUVEC) 0.1–10 µM 24 hours MK-8722 strongly inhibited HSV-1 replication, as evidenced by reduced virus particles Microbiol Spectr. 2023 Sep 13;11(5):e0041723

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice STAMTM NASH model Oral gavage 10 mg/kg Once daily for 3 weeks MK-8722 significantly reduced liver fibrosis (34%) and triglyceride content (45%) Cell Rep Med. 2020 Jul 21;1(4):100056
Mice Wild-type and AMPKγ3 knockout mice Oral 10 or 30 mg/kg body weight Single dose, monitored for 120 minutes To evaluate the effect of MK8722 on blood glucose, results showed that MK8722 significantly reduced blood glucose levels. Mol Metab. 2021 Sep;51:101228
Mice Wild-type and CARM1 muscle-specific knockout mice Oral gavage 5 mpk Single dose, euthanized after 3 hours To evaluate the effect of MK-8722 on AMPK signaling pathway, results showed that MK-8722 significantly increased the phosphorylation level of AMPK iScience. 2020 Nov 2;23(11):101755
Mice Gdf15-gut-KO and Gdf15-liver-KO mice Oral 30 mg/kg Single dose, culled 4 hours after treatment To assess the effect of MK-8722 on GDF15 levels, results showed the liver as the major contributor to the rise in serum GDF15 levels elicited by MK-8722 Sci Rep. 2024 Jan 22;14(1):1899
BALB/c nude mice Subcutaneous xenograft model Oral 30 mg/kg Every 2 days for 12 days MK8722 significantly inhibited the growth of subcutaneous xenografts in nude mice. Theranostics. 2024 Jan 1;14(1):75-95

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.22mL

0.44mL

0.22mL

11.11mL

2.22mL

1.11mL

22.23mL

4.45mL

2.22mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories